The UCW Newswire | Category

Kiwa Bio-Tech Announces Plans for Three New Biological Organic Fertilizer Manufacturing Facilities

/UCW/ ONTARIO, CA – Kiwa Bio-Tech Products Group Corporation (OTCQB:KWBT) (“Kiwa Bio-Tech” or the “Company”), an environmentally friendly Company that...

Elite Announces New Development and License Agreement with SunGen Pharma LLC

/UCW/ NORTHVALE, NJ – Elite Pharmaceuticals, Inc. (“Elite” or the “Company”) (OTCBB:ELTP), a specialty pharmaceutical company developing abuse-deterrent opioids and...

Anavex Life Sciences to Present at the 13th International Conference on Alzheimer’s and Parkinson’s Diseases AD/PD™ 2017

/UCW/ NEW YORK, NY – Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq:), a clinical-stage biopharmaceutical company developing differentiated...

Propanc Receives Patentability Opinion for Method of Treating Cancer Stem Cells

/UCW/ MELBOURNE, AUSTRALIA – Propanc Health Group Corporation (OTCQB: ) (“Propanc” or “the Company”), an emerging healthcare company focusing on...

MorphoSys to Present at Upcoming Conference

/UCW/ PLANEGG/MUNICH, GERMANY – MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX; OTC: ) will present at the following conference: LEERINK...

Wellmei Mold of Hong Kong Chosen as Lenis® Nozzle Manufacturer for Eternity

/UCW/ PHOENIX, AZ & VANCOUVER, B.C. CANADA – Eternity Healthcare Inc. (OTC: ), announces it has signed a Development and...

CURE Pharmaceutical Welcomes Industry Veteran Richard Serbin to its Advisory Board

/UCW/ OXNARD, CA – CURE Pharmaceutical (OTC QB:CURR), a preeminent developer and manufacturer of advanced oral thin film for use...

BioRestorative Therapies Submits IND Application to FDA to Treat Patients with Degenerative Disc Disease

/UCW/ MELVILLE, NY – BioRestorative Therapies, Inc. (“BRT” or the “Company”) (OTCBB: ), a life sciences company focused on stem...

GeoVax and Burnet Institute to Join Forces to Develop Malaria Vaccine

/UCW/ ATLANTA, GA – GeoVax Labs, Inc. (OTCQB: ) announced today that it has entered into a research collaboration agreement...

Roche launches cobas® c 513 analyzer and HbA1c Gen. 3 assay to meet increasing demand for testing of people with diabetes

/UCW/ INDIANAPOLIS, IN – Roche (SIX: RO, ROG; OTCQX: ) announced today that its new dedicated, high-throughput HbA1c testing solution,...

Category: Pharmaceutical